2023 ATI Pharmacology Proctored 2020 Exam’s Version 1, 2, 3 & 4, with NGN Questions and Answers (Verified Revised Full Exam)
1 / 16
ATI Pharmacology Proctored 2020 Exam with NGN
Questions
Version 1, 2, 3 & 4
Consisting of 70 Questions In Each Exam
TABLE OF CONTENTS
ATI Pharmacology Proctored NGN 2020 Exam Version 1………….2
ATI Pharmacology Proctored NGN 2020 Exam Version 2…………35
ATI Pharmacology Proctored NGN 2020 Exam Version 3………..74
ATI Pharmacology Proctored NGN 2020 Exam Version 4………..107
2 / 16
ATI PHARMACOLOGY PROCTORED EXAM 2020
WITH NGN Questions and Answers (Verified Answers)
- A nurse is assessing a client who is receiving intravenous therapy. The
nurse should identify which of the following findings as a manifestation
of fluid volume excess?
A.Decreased bowel sounds
B. Distended neck veins
C. Bilateral muscle weakness
D. Thread pulse
ANS B. Distended neck veins - A nurse is caring for a client who has hyponatremia and is receiving
an infusion of a prescribed
hypertonic solution. Which of the following findings should indicate to the
nurse that the treatment is effective?
a. Absent Chvostek’s sign
b. Improved cognition
c. Decreased vomiting
d. Cardiac arrhythmias absent
3 / 16
ANS b. Improved cognition
4 / 16
- A nurse is teaching a client who has a new prescription for a
nitroglycerin transdermal patch.
Which of the following instructions should the nurse include?
A. “Discontinue the patch if you experience a headache.”
B. “Apply a new patch if you have chest pain.”
C. “Cover the patch with dry gauze when taking a shower.”
D. “Remove the patch prior to going to bed.”
ANS D. “Remove the patch prior to goingto bed.” - A nurse is reviewing he laboratory results of a client who has aprescription for sodium polystyrene sulfonate (Kayexalate) every 6 hr. whichof the follow- ing should the nurse report to the provider?
A.Creatinine 0.72 mg/dL
B. Sodium 138 mEq/L
C. Magnesium 2 mEq/L
D. Potassium 5.2 mEq/L
ANS D. Potassium 5.2 mEq/L
Hyperkalemia (serum potassium level greater than 5.0 mEq/L)
increases the client risk for fatal cardiac dysrhythmias. Kayexalate is used to de-crease
Powered by https://learnexams.com/search/study?query=hesi